A urine methylation assay for #UrothelialCarcinoma demonstrated high sensitivity and specificity and showed higher sensitivity than urine cytology and fluorescence in situ hybridization.

A urine methylation assay for #UrothelialCarcinoma demonstrated high sensitivity and specificity and showed higher sensitivity than urine cytology and fluorescence in situ hybridization.
A urine-based assay targeting AL021918.2 and vimentin methylation demonstrated 90.8% sensitivity and 93.2% specificity for #UrothelialCarcinoma detection according to a study published in @jamanetworkopen.com
Read the full article here: https://bit.ly/4hEjpop
DAY THREE | OncoAlert at #GUARDSymposium2026 🇪🇸
🧬 What comes after enfortumab vedotin in urothelial cancer?
Dr. Jonathan E. Rosenberg 🇺🇸 from Memorial Sloan Kettering Cancer Center, New York, looks ahead to the next wave of ADCs and the biomarkers that will guide their use in #UrothelialCarcinoma 🔬